You are here: Industry Insights > china

News List

Destiny Pharma collaborates with Chinese firm biospectrumasia
December 05, 2017
As part of the deal, CMS general manager Huaizheng Peng will join the board of Destiny Pharma.
Zhongbao Chemicals -- A Professional and Trusted Chemical Products Supplier in China PharmaSources.com
December 04, 2017
Explore cooperation with ZBChem to expand chemical products business...
Current Development Situation of Valerian in China PharmaSources.com
December 01, 2017
Since 1980s, the former Jiangkou Perfumery in Jiangkou County, Guizhou Province, China had been processing wild valerian into valerian oil to export it to the European and American countries.
China: Shortage of doctors and medicine for rare diseases leads to more overseas purchase en-cphi.cn
October 25, 2017
36 specific reform measures has been proposed recently, including policies to encourage pharmaceutical products and medical devices for rare diseases, such as conditional approval for marketing...
Opportunity or challenge? Favorable policies promote the increase of drug approval(2) en-cphi.cn
October 19, 2017
China has been highly regarding medical reform in recent years, which is a challenge and development opportunity for the pharmaceutical community.
ProTom International to Install Three-Room Proton Therapy System in China prnasia
October 16, 2017
ProTom International Holding Company announces that it has signed a contract for the purchase and installation of a proton therapy system at the Boao Evergrande International Hospital in China's Hainan Province.
Which are to Dominate the Chinese HCV Drug Market: A Review of DAAs in China en-cphi.cn
October 13, 2017
So far, there are four HCV DAAs marketed in Mainland China, including the above two, BMS’ Asunaprevir soft capsule and Daclatasvir Dihydrochloride Tables combined therapy, and J & J’s Simeprevir.
China to accelerate new drug approvals by incorperating overseas trial data pharmafile
October 10, 2017
In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from clinical trials conducted overseas into its approval process for new drugs.
HanAll Biopharma and Harbour BioMed Sign Collaboration and License Agreement to Develop Two Novel Bi prnasia
September 12, 2017
HanAll Biopharma Co., Ltd. (009420.KS) and Harbour BioMed announced today that they have entered into a strategic collaboration and license agreement to develop
Prospects of VB6 are promising, with increase of price and volume and strong demand en-cphi.cn
August 18, 2017
As an important water-soluble B group vitamin, VB6 is an essential nutritional supplement to humans and animals. The market demand for it has continued to grow in recent years, and its production and sales have shown steady rise in China, with promising p

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page